PharmaVentures Podcast Series, Edition 18
Fintan Walton, founder and CEO of PharmaVentures chairs a round table discussion on this pressing issue.
Featuring;
Jim Gale. Managing Partner, Signet Healthcare Partners. A New York based Private equity firm with a wide portfolio including API medchem, Pharma Services and CDMO businesses.
Andreas Raabe: Founder & CEO of Adragos Pharma, a CDMO manufacturing in the EU and Japan.
Frank Dollard: 45 years of experience in pharmaceutical manufacturing, including GSK, BMS and Teva.
Soren Demin: Managing Director & Head of M&A at PharmaVentures and formerly senior commercial positions in multiple pharma business and a qualified medical practitioner.
In a wide-ranging discussion, hear the panelist’s views on;
- What is meant by “drug shortages” and where has the system failed?
- Where are the pinch points; manufacture, supply chains, pharma-centric influences, geopolitical events?
- The impact on manufacturers of the US Biosecure Act.
- The knock-on effects of pricing pressure on raw material sourcing.
- Increasing capacity & the role of M&A
- Can technology and innovation solve the problems?
- Where are the opportunities emerging from that will provide the solutions?